Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00088556

Public ClinicalTrials.gov record NCT00088556. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1-2a Dose-Ranging Study of the Triplet Combination of Carboplatin, Paclitaxel and TLK286 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to study the efficacy and safety of the triplet combination of TLK286, carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.

Study identification

NCT ID
NCT00088556
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Telik
Industry
Enrollment
100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2004 (Type not available)
Primary completion
May 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
May 31, 2012

2004 – 2009

United States locations

U.S. sites
52
U.S. states
12
U.S. cities
38
Facility City State ZIP Site status
Bay Area Cancer Research Group Concord California 94520 —
East Bay Medical Oncology/Hematology Associates Concord California 94520 —
Southwest Cancer Care Escondido California 92025 —
Kaiser Permanente Medical Center Hayward California 94545 —
Southwest Cancer Care Murrieta California 92562 —
Kaiser Permanente Medical Center Oakland California 94611 —
Southwest Cancer Care Poway California 92064 —
Kaiser Permanente Medical Center Sacramento California 95825 —
Kaiser Permanente Medical Center San Francisco California 94115 —
Kaiser Permanente Medical Center San Jose California 95119 —
Kaiser Permanente Medical Center Santa Clara California 95051 —
Kaiser Permanente Medical Center So. San Francisco California 94080 —
Kaiser Permanente Medical Center Vallejo California 94589 —
Diablo Valley Oncology & Hematology Medical Group Walnut Creek California 94520 —
Kaiser Permanente Medical Center Walnut Creek California 94596 —
Citrus Hematology and Oncology Crystal River Florida 34429 —
Citrus Hematology and Oncology Center Inverness Florida 34452 —
Florida Wellcare Alliance, LC Inverness Florida 34452 —
Kansas City Cancer Center Kansas City Kansas 66112 —
Kansas City Cancer Center - Central Research Dept. Data Office & Drug Discovery Location Lenexa Kansas 66214 —
Kansas City Cancer Center Overland Park Kansas 66210 —
Department of Veterns Affairs - Overton Brooks VA Medical Center Shreveport Louisiana 71101 —
LSU Health Sciences Center Shreveport Louisiana 71103 —
University of Maryland, Baltimore University of Maryland Medical System-Greenebaum Cancer Center Baltimore Maryland 21201 —
Center for Cancer and Blood Disorders, P. C. Bethesda Maryland 20817 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Kansas City Cancer Center Kansas City Missouri 64111 —
Kansas City Cancer Center Kansas City Missouri 64131 —
Kansas City Cancer Center Kansas City Missouri 64154 —
Kansas City Cancer Center Lee's Summit Missouri 64064 —
St. John's Mercy Medical Center St Louis Missouri 63141 —
St. John's Mercy Hospital Washington Missouri 63090 —
Clinical Research Service Scottsbluff Nebraska 69361 —
Horizons West Medical Group Scottsbluff Nebraska 69361 —
Dakota Cancer Institute Fargo North Dakota 58103 —
Odyssey Research Fargo North Dakota 58104 —
Tennessee Oncology, PLLC Clarksville Tennessee 37043 —
Tennessee Oncology, PLLC Franklin Tennessee 37067 —
Tennessee Oncology, PLLC Hermitage Tennessee 37076 —
Tennessee Oncology, PLLC Lebanon Tennessee 37087 —
Tennessee Oncology, PLLC Murfreesboro Tennessee 37130 —
Tennessee Oncology, PLLC Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Nashville Tennessee 37205 —
Tennessee Oncology, PLLC Nashville Tennessee 37207 —
Tennessee Oncology, PLLC Nashville Tennessee 37211 —
Tennessee Oncology, PLLC Smyrna Tennessee 37167 —
Texas Cancer Associates Dallas Texas 75231 —
Texas Cancer Associates Plano Texas 75093 —
Danville Hematology & Oncology, Inc. Danville Virginia 24541 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00088556, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2012 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00088556 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →